Navigation Links
USDA Approves Syngenta and John Deere for Broadened Biotechnology Endorsement for Corn Crop Insurance
Date:8/19/2008

WASHINGTON, Aug. 19 /PRNewswire-FirstCall/ -- Syngenta Seeds, Inc. and John Deere Risk Protection, Inc. announced today that the U.S. Department of Agriculture's Federal Crop Insurance Corporation (FCIC) has approved Syngenta Agrisure(R) and other approved biotech corn seed brands for a broadened crop insurance endorsement that provides insurance premium discounts to farmers. This extends the program for discounts of certain federally-reinsured crop insurance policies and simplified terms to growers who use multiple biotech corn suppliers.

John Deere Risk Protection, which insures growers against yield risks, and Syngenta, jointly submitted the insurance proposal to the FCIC earlier this year. The crop insurance premium discount for growers of Agrisure seeds will initially be offered in Iowa, Illinois, Indiana, Minnesota, Nebraska, South Dakota and Wisconsin. Additional program details will be announced this fall.

"The FCIC's approval of Agrisure and other traited corn seeds acknowledges reduced risk for growers," said Steve Ligon, Head, Syngenta Seeds Corn and Soybean Commercial Operations. "We worked with John Deere Risk Protection to create a better opportunity for growers to access crop insurance discounts. A unified endorsement aligns with growers' preferences for choice and the crop insurance industry's need for consistent policies across seed brands."

Mark Raymie, Director of Business Operations, John Deere Risk Protection, a managing general agent, said that approval of additional biotech seeds for a premium discount balances the interests of seed suppliers, insurers, agents, the Risk Management Agency and growers to create fair competition and broad choice. "The approval of this endorsement by the FCIC should spark additional discussions regarding how technology can impact risk reduction regardless of the technology provider," said Raymie. "We look forward to conversations that take into consideration the value of choice for grow
'/>"/>

SOURCE Syngenta
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Brazilian National Biosafety Technical Committee Approves Monsanto Company Insect-Protected Corn Trait
2. FDA Approves RISPERDAL(R) to Treat Adolescents with Schizophrenia and Children and Adolescents with Bipolar Mania
3. FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox
4. NJ Board of Pharmacy Approves Wedgewood Pharmacy Technician-Training Program
5. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
6. FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate)
7. FDA Approves Administration of LEXIVA(R) with Lower Dose of Boosting Medication Ritonavir
8. FDA Approves DORIBAX(TM) for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections
9. FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer
10. FDA Approves Genzymes Renvela(TM) for Dialysis Patients
11. FDA Approves New SPRYCEL(R) (Dasatinib) Product Labeling for Patients with Chronic-Phase CML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... -- Editor Note: For more information about ... Moments ago, Analysts Review released new research updates concerning several ... SSH ), Synergetics USA (NASDAQ: ... ), Spectranetics (NASDAQ: SPNC ), and Thoratec (NASDAQ: ... platform for investors, to hear about what matters - proudly ...
(Date:3/2/2015)... March 02, 2015 Global ... formed alliance with Shenzhen HANK Bioengineering Co., Ltd. ... The alliance will establish a stem cells training ... China in September 2015. , Shenzhen HANK is ... an award-winning scientist, microbiologist and virologist, to integrate ...
(Date:2/27/2015)... Immunovaccine Inc. (“Immunovaccine” or the “Company”) ... press release disseminated this morning by PR Web, and ... press release states that Immunovaccine has entered into a ... release did not originate from Immunovaccine and there is ... release. Please note that all official statements by ...
(Date:2/27/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/p2ddnr/global_market ) ... of Trypsin" report to their offering. , ... providing comprehensive data on Trypsin globally and regionally ( ... North America , Latin America ... Trypsin This report focuses on three primary areas; ...
Breaking Biology Technology:Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 2Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 3Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 4Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 2Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 3Immunovaccine Disclaims Hoax Press Release 2Global Market Report of Trypsin 2014-2018 2
... Gaining a first-cycle,approval for a new molecular ... incremental revenue on average, according to a new ... International (Nasdaq: PRXL ),and leading global life ... According to the PAREXEL Consulting,analysis, 60 percent of ...
... how the world communicates, and how we power ... source: nanotechnology. According to a just-released podcast and ... (PEN), nanotechnology will be central to developing advanced, ... , In the latest installment of the ...
... at the National Institute of Standards and Technology ... and the University of Colorado (CU) at Boulder, ... significantly reducing the uncertainty in delicate measurements of ... speed and precision of quantum computing and communications ...
Cached Biology Technology:PAREXEL Consulting Quantifies Speed to Market: First-Cycle Approval for NME Produces $640 Million in Incremental Revenue on Average 2PAREXEL Consulting Quantifies Speed to Market: First-Cycle Approval for NME Produces $640 Million in Incremental Revenue on Average 3PAREXEL Consulting Quantifies Speed to Market: First-Cycle Approval for NME Produces $640 Million in Incremental Revenue on Average 4PAREXEL Consulting Quantifies Speed to Market: First-Cycle Approval for NME Produces $640 Million in Incremental Revenue on Average 5First tunable, 'noiseless' amplifier may boost quantum computing, communications 2
(Date:2/5/2015)... 5, 2015  Marken is starting its 35 th ... launched a new marketing campaign to solidify its place ... new campaign focuses on First as a ... The first headline in the series, ... with its client,s priorities. Marken recognizes the need to ...
(Date:2/5/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ... authentication company focused on the growing mobile commerce market, ... Online CEO Conference on January 29 th at ... , CEO of NXT-ID will present and host a ... smart wallet and its full suite of biometric technologies. ...
(Date:1/22/2015)... Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is pleased to ... State of Washington,s Department of Licensing, in ... central issuance system for driver,s licenses and identification cards to ... and development will start in January 2015, with enrollment and ...
Breaking Biology News(10 mins):Marken Launches New Patient-Centric Campaign 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3Valid USA Signs Contract For Washington Driver's License Issuance 2
... Enough has been written and said about "platinum" open access ... models. However, comparatively little has been seen of its practical ... journals in Zoology Deutsche Entomologische Zeitschrift and ... into the future by joining the journal publishing platform of ...
... NY. (Dec. 18, 2013) Hepatocyte (liver ... acute liver failure, either for liver regeneration or ... the viability and functional aspects of hepatocytes has ... In an effort to improve both the viability ...
... Wegener Institute, Helmholtz Centre for Polar and Marine Research (AWI) ... warmer Atlantic are now reproducing in Arctic waters to the ... shift of the Arctic zooplankton community, scientists report in the ... victims of this "Atlantification" are likely to be marine birds, ...
Cached Biology News:2 of the oldest German journals in Zoology go for 'platinum' open access 2Liver cells benefit from mesenchymal stem cell co-culture prior to transplantation 2New actors in the Arctic ecosystem 2New actors in the Arctic ecosystem 3
Rab 3 Immunogen: Synthetic peptide corresponding to the N-terminal region of Rab 3 protein. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Mouse monoclonal [2G1] to Vancomycin ( Abpromise for all tested applications)....
... to LYZL6 ( Abpromise for ... Antigen: Synthetic peptide: DWLCL AFVE ... corresponding to amino acids 46-100 of ... Gene ID: 57151 ...
Mouse monoclonal [DJR3] to DcR1 (Phycoerythrin) ( Abpromise for all tested applications). entrezGeneID: 8794 SwissProtID: O14798...
Biology Products: